Big news from RAPS' news team over at Regulatory Focus: The US FDA
will resume scheduling in-person, face-to-face (FTF) formal meetings with drug and biologics sponsors beginning 13 February 2023. This link has the full news story.------------------------------
Ryan Connors
Social Media and Communications Specialist
RAPS
------------------------------